This cluster is too small to warrant a trading signal. Monitor the next earnings release for any fundamental catalyst; insider activity at these levels is noise for a $2B biotech.
PHVS drugs
PHVS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 23 $27.29entry
- T+1 · 7mo ago +4.91%α +4.13% · $28.63
- T+5 · 7mo ago +13.63%α +12.15% · $31.01
- T+20 · 6mo ago +7.92%α +3.28% · $29.45
- T+60 · 4mo ago +22.94%α +17.92% · $33.55
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Pharvaris insiders sold a total of $118K in stock over a one-week window, with the Chief Medical Officer accounting for the bulk ($112K) via option exercises and same-day sales. The dollar amount is trivial relative to the $2.0B market cap (0.006%), making this a routine cluster with no material signal.
Key Financial Metrics
Key Facts
- Three insiders sold shares totaling $118K from April 22-29, 2026
- Chief Medical Officer Lu Peng sold $112K via option exercise and same-day open-market sale
- Total cluster value is 0.006% of Pharvaris' $2.0B market cap
- Chief Early Development Officer and a Director each sold $3K, de minimis amounts
- All sales were pre-planned or routine; no insider buying in the cluster
Financial Impact
Insider sales of $118K represent 0.006% of market cap, immaterial
Risk Factors
- No material risk identified from this cluster alone
- If a larger insider sale cluster emerges (>$1M or >0.1% of market cap), it would warrant attention
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PHVS-1777677017703 |
Track record
51 reports on PHVS
15 of 18 bullish or bearish reports moved the stock their way by T+5. Best: +23.73% at T+20 after the Sep 17, 2026 report. 17 of 19 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $33.19 Now $32.44 −2.26% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $33.59 Now $32.44 +3.42% settles Nov 23
- Nov 12, 20264d ago Press Release Bullish 7/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
- Nov 12, 20264d ago 6-K Neutral 4/10 No price data
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
- Sep 25, 20267w ago Insider Cluster Bearish 6/10 Entry $32.02 to $31.19 Now $32.44 −1.31% ▲ +2.59% +2.37% vs SPY
- Sep 24, 20267w ago Insider Cluster Bearish 7/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
- Sep 24, 20267w ago Insider Cluster Bearish 5/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
- Sep 23, 20267w ago Insider Cluster Bearish 6/10 Entry $33.07 to $31.72 Now $32.44 +1.91% ▲ +4.08% +3.41% vs SPY
- Sep 21, 20268w ago Insider Cluster Bearish 5/10 Entry $36.02 to $31.91 Now $32.44 +9.94% ▲ +11.41% +10.39% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers